Assessing clinical utility of machine learning and artificial intelligence approaches to analyze speech recordings in multiple sclerosis: A pilot study-Reference-Cited by-同舟云学术

Assessing clinical utility of machine learning and artificial intelligence approaches to analyze speech recordings in multiple sclerosis: A pilot study

Published:2022-09 Issue: Volume:148 Page:105853
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Svoboda E.,Bořil T.,Rusz J.,Tykalová T.,Horáková D.^ORCID,Guttmann C.R.G.,Blagoev K.B.,Hatabu H.,Valtchinov V.I.^ORCID

Funder

Ministerstvo Školství, Mládeže a Tělovýchovy

Czech Republic Ministry of Health

European Commission

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference40 articles.

1. Multiple sclerosis review;Goldenberg;Pharmacol. Ther.,2012

2. Multiple sclerosis - a review;Dobson;Eur. J. Neurol.,2019

3. Comparison of therapies in MS patients after the first demyelinating event in real clinical practice in the Czech republic: data from the national registry ReMuS;Pavelek;Front. Neurol.,2021

4. Diagnosis and treatment of multiple sclerosis: a review;McGinley;JAMA,2021

5. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis;Bjornevik;Science,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remyelinating Drugs at a Crossroad: How to Improve Clinical Efficacy and Drug Screenings;Cells;2024-08-08

2. Vision Transformer Based Classification of Neurological Disorders from Human Speech;Firat University Journal of Experimental and Computational Engineering;2024-06-12

3. Clinical applications of deep learning in neuroinflammatory diseases: A scoping review;Revue Neurologique;2024-05

4. Using Objective Speech Analysis Techniques for the Clinical Diagnosis and Assessment of Speech Disorders in Patients with Multiple Sclerosis;Brain Sciences;2024-04-16

5. Perspective Chapter: Artificial Intelligence in Multiple Sclerosis;Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments;2024-01-31